Molecular Generation Team Manager
AqemiaLondon, England, United Kingdom • Paris, Ile-de-France, France
Posted December 8, 2025
Full Time
About the Company
Aqemia is a next-gen pharmatech company focused on drug discovery using quantum-inspired physics algorithms to power generative AI. The company designs innovative drug candidates for critical diseases like immuno-oncology without relying on experimental data, achieving several successes internally and through collaborations. Aqemia is part of the French Tech 120 program and has offices in Paris and London.
Job Description
AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. The company is looking for a Manager of Molecular Generation Team to lead the multidisciplinary team responsible for developing methods to design novel, highly potent and synthesizable molecules.
Requirements
- Master degree or PhD in Machine Learning, Computational Chemistry, Statistical Mechanics, Physics, Computer Science or a related field.
- Minimum of 2+ years of experience leading a machine learning team, computational R&D team in Drug Discovery or a closely related field.
- Proven expertise in Generative AI techniques.
- Proficiency in Python, experience with MLOps and cloud computing environments.
- Ability to translate fundamental scientific research into a clear, scalable product roadmap that aligns with commercial goals.
- Exceptional ability to communicate complex concepts to both specialized scientists and non-technical stakeholders.
- Proven ability to manage risk, handle scientific failure inherent in R&D, and lead an autonomous team in a fast-paced startup environment.
Benefits
- Strong Financial Backing: $100M raised from leading European and International investors
- Prime Location with Flexibility: Our offices are located in the heart of Paris and London (King’s Cross), with flexible work arrangements including up to two remote days per week.
- DeepTech Recognition: AQEMIA is proud to be part of the French Tech 120 and France 2030, highlighting our role as a key player in Europe’s DeepTech ecosystem.
- World-Class Interdisciplinary Team: work alongside exceptional talent at the intersection of technology and life sciences. Our teams combine deep expertise in AI, physics-based modeling, biology, and medicinal chemistry to push the boundaries of innovation.
- Expanding Drug Discovery Pipeline: Focused on critical therapeutic areas like Oncology, CNS, Immuno-inflammation... with in vivo proof of concept/patent stage programs. Collaborations with top Pharma, including a $140M Sanofi deal.